Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of the Neurolyser XR Device for the Treatment of Predominantly Medial Chronic Knee Pain Due to Osteoarthritis

NCT07178951 is registered in ClinicalTrials.gov with FUSMobile Inc. as lead sponsor.

NCT NCT07178951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07178951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of the Neurolyser XR Device for the Treatment of Predominantly Medial Chronic Knee Pain Due to Osteoarthritis
Lead sponsor
FUSMobile Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
September 9, 2026
Completion date
March 30, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic knee pain, knee pain arthritis, osteoarthritis (oa) of the knee